Skip to main content
Erschienen in: Neurological Sciences 1/2012

01.05.2012 | MIGRAINE AS A RISK FACTOR

Migraine and cardiovascular diseases

verfasst von: G. Pierangeli, G. Giannini, V. Favoni, L. Sambati, S. Cevoli, P. Cortelli

Erschienen in: Neurological Sciences | Sonderheft 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Migraine has complex relationships with cerebrovascular and cardiovascular disorders but also with cardiac anomalies. Patients affected by migraine with aura have an increased prevalence of right-to-left shunt due to patent foramen ovale or pulmonary arteriovenous malformations. The association between ischemic heart disease, cardiovascular mortality and migraine remains unsettled. The debate focuses on a physiopathological link between migraine and cardiovascular diseases or a higher prevalence of risk factors in migraineurs.
Literatur
1.
Zurück zum Zitat Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T (2009) Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 339:b3914–b3925PubMedCrossRef Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T (2009) Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 339:b3914–b3925PubMedCrossRef
2.
Zurück zum Zitat Kruit MC, Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30:129–136PubMed Kruit MC, Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30:129–136PubMed
3.
Zurück zum Zitat Schwedt TJ, Demaerschalk BM, Dodick DW (2008) Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 28:531–540PubMedCrossRef Schwedt TJ, Demaerschalk BM, Dodick DW (2008) Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 28:531–540PubMedCrossRef
4.
Zurück zum Zitat Schwedt T (2009) The migraine association with cardiac anomalies, cardiovascular disease and stroke. Neurol Clin 27(2):513–523PubMedCrossRef Schwedt T (2009) The migraine association with cardiac anomalies, cardiovascular disease and stroke. Neurol Clin 27(2):513–523PubMedCrossRef
5.
Zurück zum Zitat Sharma A, Gheewala N, Silver P (2011) Role of patent foramen ovale in migraine etiology and treatment: a review. Echocardiography 28(8):913–917 Sharma A, Gheewala N, Silver P (2011) Role of patent foramen ovale in migraine etiology and treatment: a review. Echocardiography 28(8):913–917
6.
Zurück zum Zitat Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A (2008) Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117(11):1397–1404PubMedCrossRef Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A (2008) Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117(11):1397–1404PubMedCrossRef
7.
Zurück zum Zitat Rose KM, Carson AP, Sanford CP, Stang PE, Brown CA, Folsom AR, Szklo M (2004) Migraine and other headaches. Associations with Rose angina and coronary heart disease. Neurology 63:2233–2239PubMedCrossRef Rose KM, Carson AP, Sanford CP, Stang PE, Brown CA, Folsom AR, Szklo M (2004) Migraine and other headaches. Associations with Rose angina and coronary heart disease. Neurology 63:2233–2239PubMedCrossRef
8.
Zurück zum Zitat Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE (2006) Migraine and risk of cardiovascular disease in women. JAMA 296:283–291PubMedCrossRef Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE (2006) Migraine and risk of cardiovascular disease in women. JAMA 296:283–291PubMedCrossRef
9.
Zurück zum Zitat Kurth T, Gaziano M, Cook NR, Bubes V, Logroscino G, Diener HC, Buring JE (2007) Migraine and risk of cardiovascular disease in men. Arch Intern Med 167:795–801PubMedCrossRef Kurth T, Gaziano M, Cook NR, Bubes V, Logroscino G, Diener HC, Buring JE (2007) Migraine and risk of cardiovascular disease in men. Arch Intern Med 167:795–801PubMedCrossRef
10.
Zurück zum Zitat Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB (2010) Migraine and cardiovascular disease. Neurology 74:628–635PubMedCrossRef Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB (2010) Migraine and cardiovascular disease. Neurology 74:628–635PubMedCrossRef
11.
Zurück zum Zitat Bigal ME (2011) Migraine and cardiovascular disease. Arq Neuropsiquiatr 69(1):122–129PubMed Bigal ME (2011) Migraine and cardiovascular disease. Arq Neuropsiquiatr 69(1):122–129PubMed
12.
Zurück zum Zitat Wiehe M, Fuchs SC, Moreira LB, Moraes RS, Fuchs FD (2002) Migraine is more frequent in individuals with optimal and normal blood pressure: a population-based study. J Hypertens 20:1303–1306PubMedCrossRef Wiehe M, Fuchs SC, Moreira LB, Moraes RS, Fuchs FD (2002) Migraine is more frequent in individuals with optimal and normal blood pressure: a population-based study. J Hypertens 20:1303–1306PubMedCrossRef
13.
Zurück zum Zitat Tzourio C, Gagnière B, El Amrani M, Alpérovitch A, Bousser MG (2003) Relationship between migraine, blood pressure and carotid thickness. A population-based study in the elderly. Cephalalgia 23:914–920PubMedCrossRef Tzourio C, Gagnière B, El Amrani M, Alpérovitch A, Bousser MG (2003) Relationship between migraine, blood pressure and carotid thickness. A population-based study in the elderly. Cephalalgia 23:914–920PubMedCrossRef
14.
Zurück zum Zitat Bond DS, Roth J, Nash JM, Wing RR (2011) Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes Rev 12:e362–e371PubMedCrossRef Bond DS, Roth J, Nash JM, Wing RR (2011) Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes Rev 12:e362–e371PubMedCrossRef
15.
Zurück zum Zitat Bigal ME, Liberman JN, Lipton RB (2006) Obesity and migraine: a population study. Neurology 66:545–550PubMedCrossRef Bigal ME, Liberman JN, Lipton RB (2006) Obesity and migraine: a population study. Neurology 66:545–550PubMedCrossRef
16.
Zurück zum Zitat Bigal ME, Tsang A, Loder E, Serrano D, Reed ML, Lipton RB (2007) Body mass index and episodic headaches: a population-based study. Arch Intern Med 167:1964–1970PubMedCrossRef Bigal ME, Tsang A, Loder E, Serrano D, Reed ML, Lipton RB (2007) Body mass index and episodic headaches: a population-based study. Arch Intern Med 167:1964–1970PubMedCrossRef
17.
Zurück zum Zitat Bigal ME, Lipton RB, Holland PR, Goadsby PJ (2007) Obesity, migraine and chronic migraine: possible mechanisms of interaction. Neurology 68:1851–1861PubMedCrossRef Bigal ME, Lipton RB, Holland PR, Goadsby PJ (2007) Obesity, migraine and chronic migraine: possible mechanisms of interaction. Neurology 68:1851–1861PubMedCrossRef
18.
Zurück zum Zitat Peterlin BL, Rosso AL, Rapoport AM, Scher AI (2010) Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache 50:52–62PubMedCrossRef Peterlin BL, Rosso AL, Rapoport AM, Scher AI (2010) Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache 50:52–62PubMedCrossRef
19.
Zurück zum Zitat Mattsson P (2007) Migraine headache and obesity in women aged 40–74 years: a population-based study. Cephalalgia 27:877–880PubMedCrossRef Mattsson P (2007) Migraine headache and obesity in women aged 40–74 years: a population-based study. Cephalalgia 27:877–880PubMedCrossRef
20.
Zurück zum Zitat Keith SW, Wang C, Fontaine KR, Cowan CD, Allison DB (2008) BMI and headache among women: results from 11 epidemiologic datasets. Obesity 16(2):377–383PubMedCrossRef Keith SW, Wang C, Fontaine KR, Cowan CD, Allison DB (2008) BMI and headache among women: results from 11 epidemiologic datasets. Obesity 16(2):377–383PubMedCrossRef
21.
Zurück zum Zitat Ford ES, Li C, Pearson WS, Zhao G, Strine TW, Mokdad AH (2008) Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 28:1270–1276PubMedCrossRef Ford ES, Li C, Pearson WS, Zhao G, Strine TW, Mokdad AH (2008) Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 28:1270–1276PubMedCrossRef
22.
Zurück zum Zitat Winter AC, Berger K, Buring JE, Kurth T (2009) Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia 29:269–278PubMedCrossRef Winter AC, Berger K, Buring JE, Kurth T (2009) Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia 29:269–278PubMedCrossRef
23.
Zurück zum Zitat Kurth T, Schürks M, Logroscino G, Gaziano JM, Buring JE (2008) Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 337:a636–a745PubMedCrossRef Kurth T, Schürks M, Logroscino G, Gaziano JM, Buring JE (2008) Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 337:a636–a745PubMedCrossRef
24.
Zurück zum Zitat Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ (2005) Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64:614–620PubMedCrossRef Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ (2005) Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64:614–620PubMedCrossRef
25.
Zurück zum Zitat Rist PM, Tzourio C, Kurth T (2011) Association between lipid levels and migraine: cross-sectional analysis in the Epidemiology of Vascular Ageing Study. Cephalalgia 31:1459–1465PubMedCrossRef Rist PM, Tzourio C, Kurth T (2011) Association between lipid levels and migraine: cross-sectional analysis in the Epidemiology of Vascular Ageing Study. Cephalalgia 31:1459–1465PubMedCrossRef
Metadaten
Titel
Migraine and cardiovascular diseases
verfasst von
G. Pierangeli
G. Giannini
V. Favoni
L. Sambati
S. Cevoli
P. Cortelli
Publikationsdatum
01.05.2012
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe Sonderheft 1/2012
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1040-y

Weitere Artikel der Sonderheft 1/2012

Neurological Sciences 1/2012 Zur Ausgabe

MIGRAINE AS A RISK FACTOR

Migraine: risk factor and comorbidity

FICEF SYMPOSIUM: FROM FOOD TO MIGRAINE AND BACK

Migraine and metabolism

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.